NCT00304161View on ClinicalTrials.gov

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Depressive DisorderParkinson Disease
Interventions
DRUG

Atomoxetine

40 to 80 mg orally once daily for 8 weeks

DRUG

Placebo

40 to 80 mg orally once daily for 8 weeks

Trial Locations (2)

19104

Philadelphia Veterans Affairs Medical Center, Philadelphia

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00304161 - Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease | Biotech Hunter | Biotech Hunter